Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human induced pluripotent stem cell-derived cortical grafts rebuild motor circuits after brain injury.

Neural regeneration research·2026
Same author

Modest Neurodevelopment Impacts of <italic>APOE4</italic> in a Human Brain Organoid Model of Low-Grade SARS-CoV-2 Infection.

Developmental neuroscience·2026
Same author

Dual developmental effects of ARX poly-alanine mutations on human cortical excitatory and inhibitory neurons.

Cell reports·2025
Same author

The Specification and Functional Maturation of Sub-Cerebral Projection Neurons Derived from Human Induced Pluripotent Stem Cells.

Stem cells and development·2025
Same author

Information content as a health system screening tool for rare diseases.

NPJ digital medicine·2025
Same author

Regulation of neurogenesis and neuronal migration by Rrm2 and Timp3 following seizures.

Neurobiology of disease·2025

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids
06:30

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids

Published on: September 27, 2024

2.0K

Stem cells: A path towards improved epilepsy therapies.

Zane R Lybrand1, Sonal Goswami1, Jenny Hsieh1

  • 1Department of Biology and Brain Health Consortium, The University of Texas at San Antonio, San Antonio, TX, USA.

Neuropharmacology
|September 21, 2019
PubMed
Summary

Patient-derived induced pluripotent stem cells (iPSCs) offer a promising avenue for epilepsy research and personalized medicine. This technology facilitates drug discovery and potential stem cell therapies for treatment-resistant epilepsy.

Keywords:
Anti-Seizure drugsDrug discoveryEpilepsyHuman induced pluripotent stem cellsPersonalized medicine

More Related Videos

Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
05:00

Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders

Published on: November 11, 2022

2.9K
Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids
06:30

Author Spotlight: Advancing Genetic Epilepsy Studies with Multi-Electrode Array-Based Long-Term Electrophysiological Monitoring of Human Brain Assembloids

Published on: September 27, 2024

2.0K
Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
05:00

Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders

Published on: November 11, 2022

2.9K
Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Epilepsy affects millions, with a significant portion resistant to current anti-seizure drugs (ASDs).
  • Rapid advancements in gene sequencing identify new epilepsy genes faster than in vivo models can be developed.
  • Patient-derived induced pluripotent stem cells (iPSCs) offer a viable alternative for disease modeling and drug screening.

Purpose of the Study:

  • To review the current applications of iPSCs in epilepsy research.
  • To highlight the need for high-throughput drug screening (HTS) in epilepsy.
  • To discuss the potential of stem cell therapy for epilepsy.

Main Methods:

  • Review of existing literature on iPSC technology in epilepsy.
  • Analysis of progress in phenotype and assay development for HTS.
  • Discussion of autologous transplantation strategies using stem cells.

Main Results:

  • iPSCs provide a patient-specific in vitro model for studying genetic epilepsies.
  • Significant progress has been made in developing assays for HTS using iPSCs.
  • iPSC technology is emerging as a tool for personalized medicine in epilepsy treatment.

Conclusions:

  • iPSC technology holds significant promise for advancing epilepsy research, drug discovery, and personalized medicine.
  • Further development in HTS and stem cell therapy applications is crucial for clinical translation.
  • This approach could revolutionize the treatment landscape for drug-resistant epilepsy.